Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 54

Results For "ADA"

854 News Found

Atik Cameras launches ChemiMOS for long exposure imaging
Medical Device | June 22, 2022

Atik Cameras launches ChemiMOS for long exposure imaging

Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications


Cadila Pharma launches formulation development lab
News | June 21, 2022

Cadila Pharma launches formulation development lab

The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab


GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
People | June 17, 2022

GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer

Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics


Valo Therapeutics appoints Hemanshu Shah as Chief Business Officer
People | June 17, 2022

Valo Therapeutics appoints Hemanshu Shah as Chief Business Officer

We see significant potential in working with oncolytic virus companies and Neo antigen-companies


Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research
Public Health | June 16, 2022

Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research

The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.


QIAGEN selects TCS for cloud transformation strategy
Digitisation | June 16, 2022

QIAGEN selects TCS for cloud transformation strategy

QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth


Philips announces positive research results from its TOBA II BTK clinical trial
Diagnostic Center | June 14, 2022

Philips announces positive research results from its TOBA II BTK clinical trial

First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization


FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Drug Approval | June 14, 2022

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial


Isotopia and CPDC deliver first doses of n.c.a. Lu-177 to North American customers
News | June 12, 2022

Isotopia and CPDC deliver first doses of n.c.a. Lu-177 to North American customers

The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America


Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis
Diagnostic Center | June 12, 2022

Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis

Amarex Clinical Research guides its client to phase II of FDA trials